熱門資訊> 正文
杰富瑞（Jefferies）因季度业绩令人失望而下调Cryoport评级
2024-08-07 23:53
- Jefferies has downgraded Cryoport (NASDAQ:CYRX) to buy from hold to a slowing growth outlook.
- The firm revised its price target to $8 from $20 (3% upside based on Aug. 7 close).
- Analyst Matthew Stanton noted that he expects the "stock to remain in penalty box as it will take time for management to rebuild credibility around forecasting after cutting guidance mid-year for the third straight year."
- He also questions whether the company's MVE Biological Solutions segment, one of its core businesses that provides cryogenic freezer systems, can meet management's growth expectations.
- At the same time, Stanton said that while some of Cryoport's other businesses are poised for growth, they are relatively small and will likely not contribute much to drive significant growth for the company.
- Despite the downgrade, shares are up ~4% in Wednesday trading.
More on CryoPort
- Cryoport, Inc. (CYRX) Q2 2024 Earnings Call Transcript
- Cryoport: Still Not Cool Enough
- Cryoport announces $200M repurchase program and repurchase of $160M of convertible senior notes
- CryoPort GAAP EPS of -$1.62 misses by $1.22, revenue of $57.6M misses by $0.08M
- Seeking Alpha’s Quant Rating on CryoPort
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
